The GuardianSanofi GSK and Sanofi to start human trials of potential Covid-19 vaccine verified_publisherThe Guardian - Joanna PartridgeWorld’s largest vaccine makers to begin testing on people in US with eye on rollout in early 2021 GlaxoSmithKline and Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the...
Global NewsCoronavirus (COVID-19) Canadian company to collaborate on potential coronavirus vaccine with GSK Global News - Staff The world’s largest vaccine-maker GSK has put its vaccine booster technology to work in a potential new COVID-19 shot, to be developed with a …
Immune System Sanofi and GSK delay Covid vaccine after low immune response in trials independent.co.uk - Isobel Frodsham Two pharmaceutical companies that are developing a Covid-19 vaccine have delayed their programme after trials showed a low immune response in older …
Associated PressCOVID-19 Vaccine Sanofi, GSK to provide COVID-19 vaccine to global alliance Associated Press - APLONDON (AP) — Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine to the COVAX Facility, a collaboration designed to give countries around...
South China Morning Post News UK to secure 60 million doses of virus vaccine from Sanofi, GSK verified_publisherSouth China Morning Post - Reuters According to a newspaper report, Britain was considering taking an option to buy the vaccine should it work in human trials.
CNBCSanofi Sanofi, GSK to provide 200 million Covid vaccine doses to WHO global immunization program verified_publisherCNBC - Will Feuer European drugmakers Sanofi and GlaxoSmithKline will provide 200 million doses of their Covid-19 vaccine to the World Health Organization's global …
Sanofi Sanofi and GSK move Covid-19 vaccine into human trials statnews.com - Helen Branswell Vaccine giants Sanofi and GSK are joining the ranks of Covid-19 vaccine makers testing their candidates in people, launching a large Phase 1/2 …
BBC NewsVaccination GSK and Sanofi make global Covid vaccine supply deal verified_publisherBBC NewsDrug companies GSK and Sanofi will supply 200 million doses of their coronavirus vaccine candidate to a global inoculation scheme. The two companies' vaccine is going through the first stages of testing....
